Hjem › Rabdomiosarkom › Pennsylvania
Kliniske studier for Rabdomiosarkom i Pennsylvania
5 studier for Rabdomiosarkom søker deltakere på steder i Pennsylvania.
Byer i Pennsylvania
Offisiell studietekst (engelsk)
Phase I Trial to Determine the Dose and Evaluate the PK and Safety of Lutetium Lu 177 Edotreotide Therapy in Pediatric Participants With SSTR-positive Tumors
- The Children's Hospital of Philadelphia (CHOP), Philadelphia
RekruttererFase 1
24 Months – 18 Years · Alle kjønn · Oppdatert 25. sep. 2026 · NCT06441331Silmitasertib (CX-4945) in Combination With Chemotherapy for Relapsed Refractory Solid Tumors
- Penn State Milton S. Hershey Medical Center and Children's Hospital, Hershey
RekruttererFase 1/2
Opp til 30 år · Alle kjønn · Oppdatert 3. sep. 2026 · NCT06541262A Study Comparing Higher Dose Chemotherapy Over a Shorter Amount of Time to Lower Dose Chemotherapy Plus Maintenance Over a Longer Amount of Time in Patients With Newly Diagnosed Intermediate-Risk Rhabdomyosarcoma (IR RMS)
- Lehigh Valley Hospital-Cedar Crest, Allentown
- Children's Hospital of Philadelphia, Philadelphia
- Saint Christopher's Hospital for Children, Philadelphia
- og 1 flere
RekruttererFase 3
Opp til 50 år · Alle kjønn · Oppdatert 25. aug. 2026 · NCT07466316PEEL-224, Vincristine and Temozolomide in Pediatric Solid Tumors
- Children's Hospital of Philadelphia, Philadelphia
RekruttererFase 1/2
Alder 1 til 30 · Alle kjønn · Oppdatert 22. jul. 2026 · NCT06721689VITAS: Atezolizumab in Combination With Chemotherapy for Pediatric Relapsed/Refractory Solid Tumors
- Children's Hospital of Philadelphia, Philadelphia
RekruttererFase 1/2
6 Months – 30 Years · Alle kjønn · Oppdatert 2. jun. 2026 · NCT04796012Fra ClinicalTrials.gov, data hentet 5. okt. 2026. Hver studie setter sine egne kvalifikasjonskrav; studieteamet avgjør hvem som kan delta.